Institute of Pharmaceutical Biology, Goethe-University, 60438 Frankfurt am Main, Germany.
Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany.
Viruses. 2023 Apr 20;15(4):1016. doi: 10.3390/v15041016.
Many patients with ongoing complaints after a SARS-CoV-2 infection are treated in primary care. Existing medical guidelines on how to diagnose and treat Long-/Post-COVID are far from being comprehensive. This study aims to describe how German general practitioners (GPs) deal with this situation, what problems they experience when managing such patients, and how they solve problems associated with the diagnosis and treatment of Long-/Post-COVID.
We conducted a qualitative study and interviewed 11 GPs. The most commonly described symptoms were ongoing fatigue, dyspnea, chest tightness and a decrease in physical capacity. The most common way to identify Long-/Post-COVID was by exclusion. Patients suffering from Long-/Post-COVID were generally treated by their GPs and rarely referred. A very common non-pharmacological intervention was to take a wait-and-see approach and grant sick leave. Other non-pharmacological interventions included lifestyle advices, physical exercise, acupuncture and exercises with intense aromas. Pharmacological treatments focused on symptoms, like respiratory symptoms or headaches. Our study's main limitations are the small sample size and therefore limited generalizability of results.
Further research is required to develop and test pharmaceutical and non-pharmaceutical interventions for patients with Long-/Post-COVID. In addition, strategies to prevent the occurrence of Long-/Post-COVID after an acute infection with SARS-CoV-2 have to be developed. The routine collection of data on the diagnosis and management of Long-/Post-COVID may help in the formulation of best practices. It is up to policymakers to facilitate the necessary implementation of effective interventions in order to limit the huge societal consequences of large groups of patients suffering from Long-/Post-COVID.
许多患有持续性新冠病毒感染后症状的患者在初级保健机构接受治疗。现有的关于如何诊断和治疗长新冠/后新冠的医学指南远远不够全面。本研究旨在描述德国全科医生(GP)如何处理这种情况,他们在管理此类患者时遇到的问题,以及他们如何解决与长新冠/后新冠诊断和治疗相关的问题。
我们进行了一项定性研究,采访了 11 名全科医生。最常描述的症状是持续疲劳、呼吸困难、胸闷和体力下降。识别长新冠/后新冠的最常见方法是通过排除法。患有长新冠/后新冠的患者通常由他们的 GP 治疗,很少转介。一种非常常见的非药物干预方法是静观其变并给予病假。其他非药物干预措施包括生活方式建议、体育锻炼、针灸和使用强烈气味的运动。药物治疗侧重于症状,如呼吸道症状或头痛。我们研究的主要局限性是样本量小,因此结果的普遍性有限。
需要进一步研究为长新冠/后新冠患者开发和测试药物和非药物干预措施。此外,必须制定策略来预防 SARS-CoV-2 急性感染后长新冠/后新冠的发生。常规收集长新冠/后新冠的诊断和管理数据可能有助于制定最佳实践。政策制定者有责任促进必要的实施,以限制大量患有长新冠/后新冠的患者带来的巨大社会后果。